Randomized Controlled Trial to Evaluate Feasibility and Safety of Granulocyte Colony-Stimulating Factor Treatment in Patients with Acute Myocardial Infarction

Randomized Controlled Trial to Evaluate Feasibility and Safety of Granulocyte Colony-Stimulating Factor Treatment in Patients with Acute Myocardial Infarction - Effects of G-CSF on AMI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-C000000152

Enrollment

Registered

2005-10-01

Start date

2003-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction

Interventions

filgrastim 2.5microgram/kg/day x 5days saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: AMI patients with total coronary occulusion and successful PCI

Exclusion criteria

Exclusion criteria: previous MI persistent severe heart failure uncontrolled myocardial ischemia malignant disease

Design outcomes

Primary

Measure	Time frame
changes between global LVEF,LVESV and LVEDV at baseline and those after 6 months follow-up	—

Countries

Japan

Contacts

Public ContactHiroyuki Takano

Chiba University Graduate School of Medicine Department of Cardiovascular Science and Medicine

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026